Nicolas Gendron to Middle Aged
This is a "connection" page, showing publications Nicolas Gendron has written about Middle Aged.
Connection Strength
0.060
-
Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital Mortality. Arthritis Rheumatol. 2021 11; 73(11):1976-1985.
Score: 0.015
-
Usefulness of initial plasma dabigatran concentration to predict rebound after reversal. Haematologica. 2018 05; 103(5):e226-e229.
Score: 0.012
-
Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance. Angiogenesis. 2021 08; 24(3):407-411.
Score: 0.004
-
D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study. Arch Cardiovasc Dis. 2021 May; 114(5):381-393.
Score: 0.004
-
Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study. J Am Heart Assoc. 2021 04 20; 10(8):e018624.
Score: 0.004
-
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis. 2021 08; 24(3):505-517.
Score: 0.004
-
Multidimensional Proteomic Approach of Endothelial Progenitors Demonstrate Expression of KDR Restricted to CD19 Cells. Stem Cell Rev Rep. 2021 04; 17(2):639-651.
Score: 0.004
-
Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study. Thromb Res. 2021 01; 197:94-99.
Score: 0.004
-
Curative anticoagulation prevents endothelial lesion in COVID-19 patients. J Thromb Haemost. 2020 09; 18(9):2391-2399.
Score: 0.004
-
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. 2020 11; 23(4):611-620.
Score: 0.004
-
[Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version]. Rev Mal Respir. 2019 Feb; 36(2):249-283.
Score: 0.003